Prognostic Impact of NPM1 and FLT3 Mutations at Diagnosis and Presence of Measurable Residual Disease (MRD) after Intensive Chemotherapy (IC) for Patients with Acute Myeloid Leukemia (AML) in Remission: Outcomes from the QUAZAR AML-001 Trial of Oral Azacitidine (Oral-AZA) Maintenance

Hartmut Döhner,Andrew H Wei,Gail J Roboz,Pau Montesinos,Felicitas R Thol,Farhad Ravandi,Hervé Dombret,Kimmo Porkka,Irwindeep Sandhu,Barry Skikne,Wendy L See,Manuel Ugidos,Alberto Risueño,Esther Chan,Anjan Thakurta,C.L Beach,Daniel Lopes De Menezes

doi:10.1182/blood-2021-147465

Prognostic Impact of NPM1 and FLT3 Mutations at Diagnosis and Presence of Measurable Residual Disease (MRD) after Intensive Chemotherapy (IC) for Patients with Acute Myeloid Leukemia (AML) in Remission: Outcomes from the QUAZAR AML-001 Trial of Oral Azacitidine (Oral-AZA) Maintenance

Hartmut Döhner, Andrew H Wei + Show 15 more

Open Access

https://doi.org/10.1182/blood-2021-147465

Copy DOI

Journal: Blood	Publication Date: Nov 5, 2021
Citations: 3

Affiliation: University Hospital Ulm, The Alfred Hospital, Cornell University, NewYork–Presbyterian Hospital, Hospital Universitari i Politècnic La Fe, Hochschule Hannover, Hannover Medical School, The University of Texas MD Anderson Cancer Center, Hôpital Saint-Louis, Assistance Publique – Hôpitaux de Paris, Université Paris Cité, University of Helsinki, Helsinki University Hospital, University of Alberta, University of Kansas Medical Center, University Medical Center, University Hospital and Clinics, Bristol-Myers Squibb (United States)

#Measurable Residual Disease #Placebo In Pts + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Prognostic Impact of NPM1 and FLT3 Mutations at Diagnosis and Presence of Measurable Residual Disease (MRD) after Intensive Chemotherapy (IC) for Patients with Acute Myeloid Leukemia (AML) in Remission: Outcomes from the QUAZAR AML-001 Trial of Oral Azacitidine (Oral-AZA) Maintenance

Full Text

Paper version not known

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Blood

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.